Quarter Period Statement Of Income

Delta-Fly Pharma, Inc. - Filing #7583108

Concept 2022-04-01 to
2022-09-30
2021-04-01 to
2021-09-30
Quarter period statement of income
Statement of income
Selling, general and administrative expenses
Remuneration for directors (and other officers)
43,600,000 JPY
44,224,000 JPY
Operating profit (loss)
-611,632,000 JPY
-554,097,000 JPY
Non-operating income
Interest income
7,000 JPY
61,000 JPY
Non-operating income
15,000 JPY
182,000 JPY
Non-operating expenses
Non-operating expenses
9,341,000 JPY
1,938,000 JPY
Ordinary profit (loss)
-620,957,000 JPY
-555,854,000 JPY
Profit (loss) before income taxes
-620,957,000 JPY
-555,854,000 JPY
Income taxes - current
1,628,000 JPY
1,611,000 JPY
Income taxes
1,628,000 JPY
1,611,000 JPY
Profit (loss)
-622,585,000 JPY
-557,465,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.